摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

TTA-Q5 | 1213235-34-7

中文名称
——
中文别名
——
英文名称
TTA-Q5
英文别名
(4S)-6-chloro-4-cyclopropyl-4-(4-fluorophenyl)-3-(2,2,2-trifluoroethyl)-1H-quinazolin-2-one
TTA-Q5化学式
CAS
1213235-34-7
化学式
C19H15ClF4N2O
mdl
——
分子量
398.788
InChiKey
NJOILYDPOPVIIT-IBGZPJMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    491.5±45.0 °C(Predicted)
  • 密度:
    1.426±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    27
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    参考文献:
    名称:
    Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel Antagonists
    摘要:
    A novel series of quinazolinone T-type calcium channel antagonists have been prepared and evaluated using in vitro and in vivo assays. Optimization of the screening hit 3 by modifications of the 3- and 4-positions of the quinazolinone ring afforded potent and selective antagonists that displayed in vivo central nervous system efficacy in epilepsy and tremor models, as well as significant effects on rat active wake as measured by electrocorticogram.
    DOI:
    10.1021/ml100004r
点击查看最新优质反应信息

文献信息

  • USES, COMPOSITIONS AND METHODS
    申请人:Fisahn Andre
    公开号:US20210038589A1
    公开(公告)日:2021-02-11
    The present invention relates generally to calcium channel inhibitors for use in treating and/or preventing an amyloid disease of the nervous system. The invention also relates to related pharmaceutical compositions, kits and screening methods.
  • T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF
    申请人:Praxis Precision Medicines, inc.
    公开号:US20210128537A1
    公开(公告)日:2021-05-06
    Described herein are compounds useful for preventing and/or treating a disease or condition relating to aberrant function of a T-type calcium channel, such as epilepsy and epilepsy syndromes (e.g., absence seizures, juvenile myoclonic epilepsy, or a genetic epilepsy) and mood disorders. The present invention further comprises methods for modulating the function of a T-type calcium channel.
查看更多